— Know what they know.
Not Investment Advice

LGVN NASDAQ

Longeveron Inc.
1W: -8.2% 1M: -62.0% 3M: -60.2% YTD: -56.5% 1Y: -65.2% 3Y: -98.9% 5Y: -99.3%
$2.58
-0.01 (-0.39%)
 
Weekly Expected Move ±32.2%
$1 $2 $3 $3 $4
NASDAQ · Healthcare · Biotechnology · Tech Score Strong Sell · Power 23 · $7.9M mcap · 2M float · 2.89% daily turnover · Short 46% of daily vol

Supply Chain Overview

2 relationships
2
As Filer
counterparties named
0
As Counterparty
mentioned by others
1
Rel. Types
2023-08-18
Earliest Filing
2025-09-19
Latest Filing
partner: 2

Counterparties (Filed by LGVN)

2 relationships

Companies named in LGVN's SEC 8-K filings as business counterparties.

Counterparty Ticker Relationship Summary Filing Date SEC
H.C. Wainwright & Co., LLC — partner Sales agent for the Company's At The Market Offering program 2025-09-19 View
R.F. Lafferty & Co., Inc. — partner Dealer-manager appointed for the Company's rights offering 2023-08-18 View
Recent 8-K Filings (20)
Filing Date Description Type SEC
2026-09-23 Other Events; Exhibits View
2026-09-14 Other Events View
2026-08-24 Bylaws Amendment; Regulation FD; Exhibits View
2026-08-19 Officer/Director Change; Exhibits View
2026-08-12 Earnings Release; Exhibits View
2026-07-29 Other Events View
2026-07-14 Officer/Director Change; Exhibits View
2026-07-08 Officer/Director Change View
2026-07-06 Officer/Director Change; Bylaws Amendment; Shareholder Vote; Exhibits View
2026-06-05 Officer/Director Change View
2026-05-13 Earnings Release; Exhibits View
2026-05-08 Other Events; Exhibits View
2026-04-10 Officer/Director Change; Exhibits View
2026-03-25 Delisting Notice View
2026-03-24 Other Events View
2026-03-12 Entry into Material Definitive Agreement; Unregistered Sales of Equity Securities; Amendments to Art Agreement View
2026-03-09 Notice of Delisting or Transfer; Departure/Election of Directors; Appointment of Officers View
2026-02-13 Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits View
2025-11-12 Departure/Election of Directors; Appointment of Officers View
2025-11-04 Results of Operations and Financial Condition; Financial Statements and Exhibits View
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text. Covers 2021–2026. View on SEC EDGAR

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms